192 related articles for article (PubMed ID: 19072985)
1. SMARCB1/INI1 alterations and hepatoblastoma: another extrarenal rhabdoid tumor revealed?
Russo P; Biegel JA
Pediatr Blood Cancer; 2009 Mar; 52(3):312-3. PubMed ID: 19072985
[No Abstract] [Full Text] [Related]
2. Malignant rhabdoid tumor mimicking hepatoblastoma: a case report and literature review.
Wagner LM; Garrett JK; Ballard ET; Hill DA; Perry A; Biegel JA; Collins MH
Pediatr Dev Pathol; 2007; 10(5):409-15. PubMed ID: 17929989
[TBL] [Abstract][Full Text] [Related]
3. Infrequent SMARCB1/INI1 gene alteration in epithelioid sarcoma: a useful tool in distinguishing epithelioid sarcoma from malignant rhabdoid tumor.
Kohashi K; Izumi T; Oda Y; Yamamoto H; Tamiya S; Taguchi T; Iwamoto Y; Hasegawa T; Tsuneyoshi M
Hum Pathol; 2009 Mar; 40(3):349-55. PubMed ID: 18973917
[TBL] [Abstract][Full Text] [Related]
4. Highly aggressive behavior of malignant rhabdoid tumor: a special reference to SMARCB1/INI1 gene alterations using molecular genetic analysis including quantitative real-time PCR.
Kohashi K; Oda Y; Yamamoto H; Tamiya S; Izumi T; Ohta S; Taguchi T; Suita S; Tsuneyoshi M
J Cancer Res Clin Oncol; 2007 Nov; 133(11):817-24. PubMed ID: 17486366
[TBL] [Abstract][Full Text] [Related]
5. A novel mutation of the SMARCB1 gene in a case of extrarenal malignant rhabdoid tumor.
Koitabashi M; Kanazawa T; Tamura K; Tsukada S; Suzuki M; Morikawa A; Ogawa C; Hirado J
Cancer Genet Cytogenet; 2008 Feb; 181(1):67-8. PubMed ID: 18262058
[No Abstract] [Full Text] [Related]
6. Detection of SMARCB1 loss in ascites cells in the diagnosis of an abdominal rhabdoid tumor.
Kerl K; Oyen F; Leuschner I; Schneppenheim R; Nagel I; Siebert R; Groll AH; Hartmann W; Barth PJ; Bartelheim K; Seringer A; Wardelmann E; Frühwald MC
Pediatr Blood Cancer; 2015 May; 62(5):897-900. PubMed ID: 25663425
[TBL] [Abstract][Full Text] [Related]
7. Mutation of the INI1 gene in composite rhabdoid tumor of the endometrium.
Donner LR; Wainwright LM; Zhang F; Biegel JA
Hum Pathol; 2007 Jun; 38(6):935-9. PubMed ID: 17376508
[TBL] [Abstract][Full Text] [Related]
8. Re: Infrequent SMARCB1/INI1 gene alteration in epithelioid sarcoma: a useful tool in distinguishing epithelioid sarcoma from malignant rhabdoid tumor: Direct evidence of mutational inactivation of SMARCB1/INI1 in epithelioid sarcoma.
Flucke U; Slootweg PJ; Mentzel T; Pauwels P; Hulsebos TJ
Hum Pathol; 2009 Sep; 40(9):1361-2; author reply 1362-4. PubMed ID: 19683621
[No Abstract] [Full Text] [Related]
9. The role of SMARCB1/INI1 in development of rhabdoid tumor.
Roberts CW; Biegel JA
Cancer Biol Ther; 2009 Mar; 8(5):412-6. PubMed ID: 19305156
[TBL] [Abstract][Full Text] [Related]
10. Small cell undifferentiated (SCUD) hepatoblastomas: All malignant rhabdoid tumors?
Vokuhl C; Oyen F; Häberle B; von Schweinitz D; Schneppenheim R; Leuschner I
Genes Chromosomes Cancer; 2016 Dec; 55(12):925-931. PubMed ID: 27356182
[TBL] [Abstract][Full Text] [Related]
11. Imprinted CDKN1C is a tumor suppressor in rhabdoid tumor and activated by restoration of SMARCB1 and histone deacetylase inhibitors.
Algar EM; Muscat A; Dagar V; Rickert C; Chow CW; Biegel JA; Ekert PG; Saffery R; Craig J; Johnstone RW; Ashley DM
PLoS One; 2009; 4(2):e4482. PubMed ID: 19221586
[TBL] [Abstract][Full Text] [Related]
12. Introduction from the editor.
Biegel J
Cancer Genet; 2014 Sep; 207(9):345. PubMed ID: 25434579
[No Abstract] [Full Text] [Related]
13. Nonsense mutation and inactivation of SMARCA4 (BRG1) in an atypical teratoid/rhabdoid tumor showing retained SMARCB1 (INI1) expression.
Hasselblatt M; Gesk S; Oyen F; Rossi S; Viscardi E; Giangaspero F; Giannini C; Judkins AR; Frühwald MC; Obser T; Schneppenheim R; Siebert R; Paulus W
Am J Surg Pathol; 2011 Jun; 35(6):933-5. PubMed ID: 21566516
[TBL] [Abstract][Full Text] [Related]
14. Uterine neoplasms composed of rhabdoid cells do not exhibit loss of INI1 immunoreactivity and are not related to childhood malignant rhabdoid tumor.
Al-Hussaini M; Hirschowitz L; McCluggage WG
Int J Gynecol Pathol; 2008 Apr; 27(2):236-42. PubMed ID: 18317218
[TBL] [Abstract][Full Text] [Related]
15. Rhabdoid tumors: clinical approaches and molecular targets for innovative therapy.
Kerl K; Holsten T; Frühwald MC
Pediatr Hematol Oncol; 2013 Oct; 30(7):587-604. PubMed ID: 23848359
[TBL] [Abstract][Full Text] [Related]
16. Prenatal presentation of a metastasizing rhabdoid tumor with homozygous deletion of the SMARCB1 gene.
Negahban S; Nagel I; Soleimanpour H; Aledavood A; Bagheri N; Paydar M; Daneshbod K; Hasselblatt M; Gesk S; Siebert R; Daneshbod Y
J Clin Oncol; 2010 Nov; 28(33):e688-91. PubMed ID: 20805448
[No Abstract] [Full Text] [Related]
17. Integrated genomics has identified a new AT/RT-like yet INI1-positive brain tumor subtype among primary pediatric embryonal tumors.
Ho DM; Shih CC; Liang ML; Tsai CY; Hsieh TH; Tsai CH; Lin SC; Chang TY; Chao ME; Wang HW; Wong TT
BMC Med Genomics; 2015 Jun; 8():32. PubMed ID: 26109171
[TBL] [Abstract][Full Text] [Related]
18. Pathology and diagnosis of SMARCB1-deficient tumors.
Margol AS; Judkins AR
Cancer Genet; 2014 Sep; 207(9):358-64. PubMed ID: 25246033
[TBL] [Abstract][Full Text] [Related]
19. SMARCB1/INI1 protein expression in round cell soft tissue sarcomas associated with chromosomal translocations involving EWS: a special reference to SMARCB1/INI1 negative variant extraskeletal myxoid chondrosarcoma.
Kohashi K; Oda Y; Yamamoto H; Tamiya S; Oshiro Y; Izumi T; Taguchi T; Tsuneyoshi M
Am J Surg Pathol; 2008 Aug; 32(8):1168-74. PubMed ID: 18580682
[TBL] [Abstract][Full Text] [Related]
20. The requirement for SNF5/INI1 in adipocyte differentiation highlights new features of malignant rhabdoid tumors.
Caramel J; Medjkane S; Quignon F; Delattre O
Oncogene; 2008 Mar; 27(14):2035-44. PubMed ID: 17922027
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
